Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513728 · ClinicalTrials.gov registry record · NA
Pilot Study of Methadone Patient Access to Collaborative Treatment: a HEAL Initiative
A NA study of Patients and Opioid Substitution Treatment Clinics, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT06513728: Completed NA study of Patients and Opioid Substitution Treatment Clinics, sponsored by University of Arizona.
NCT06513728 is a NA study of Patients and Opioid Substitution Treatment Clinics that has completed, run by University of Arizona. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06513728, a NA study of Patients and Opioid Substitution Treatment Clinics, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
Examine the preliminary effect of the MPACT intervention on methadone treatment retention, in treatment overdose and patient trauma symptoms. The study will also explore the relationship between staff trauma symptoms and MPACT implementation.
Primary Outcome
Retention in methadone treatment (measured by 3 different indicators)
Conditions Studied
Interventions
- OTHER MPACT Intervention
Study Locations (1)
Arizona
- University of Arizona College of Medicine - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2024-09-26 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What the finished NCT06513728 record still lists
NCT06513728 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Patients appearing as the primary indexed condition, and to 1 intervention - of which MPACT Intervention is the first listed.
NCT06513728 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06513728 about?
NCT06513728 is a clinical study titled "Pilot Study of Methadone Patient Access to Collaborative Treatment: a HEAL Initiative". Examine the preliminary effect of the MPACT intervention on methadone treatment retention, in treatment overdose and patient trauma symptoms. The study will also explore the relationship between staff trauma symptoms and MPACT implementation.
What is the current status of trial NCT06513728?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2024-09-26. Estimated completion is 2025-04-30.
What conditions does trial NCT06513728 study?
This clinical trial studies the following conditions: Patients, Opioid Substitution Treatment Clinics, Staff.
What interventions are being tested in trial NCT06513728?
The interventions under investigation include: MPACT Intervention (OTHER).
Who is sponsoring clinical trial NCT06513728?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06513728 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06513728's enrollment target sits among peer trials
102 837th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI